Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Myristoylated-peptidyl-recombinant Human CD59

EU orphan designation number: EU/3/02/114
Active ingredient: Myristoylated-peptidyl-recombinant Human CD59
Indication: Treatment of paroxysmal nocturnal haemoglubinuria
Sponsor: Orexo AB
Virdings Allé 32 A, SE-754 50 Uppsala, Svërige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/09/2002 Orphan designation EMEA/OD/016/02 (2002)3402 of 11/09/2002
29/06/2007 Change of name and/or address of sponsor
30/09/2008 Transfer of orphan designation EMEA/OD/016/02/T/01 (2008)5594 of 26/09/2008
03/03/2009 Removal of orphan designation from Community Register